New Seven Up Score Reduces Unnecessary Steroid Treatment for Liver Transplant Recipients

A groundbreaking study published in Hepatobiliary & Pancreatic Diseases International introduces the Seven Up score, a novel diagnostic framework designed to optimize post-transplant care. By combining routine day 7 biopsy findings with specific blood marker trends, researchers found that clinicians can accurately distinguish between patients who truly require intervention and those whose early rejection episodes will resolve spontaneously. This shift in methodology challenges the traditional reliance on biopsy-only diagnosis, which often leads to the over-treatment of stable patients.

Led by Prof. Jan P. Lerut at Université catholique de Louvain, the study analyzed 421 liver transplant recipients to validate this bio-histological approach. Results indicated that while over 37% of patients displayed histological signs of rejection, only 4.5% required actual medical therapy. By applying the Seven Up criteria, medical teams successfully spared nearly one-third of the cohort from potentially harmful, unnecessary steroid pulses without compromising long-term graft survival or patient outcomes.

This innovative scoring system offers a practical, objective pathway toward personalized immunosuppression management. By reducing the frequency of aggressive steroid treatments, clinicians can mitigate the risks of severe long-term complications, such as metabolic disorders and infections. As the medical community moves toward minimizing immunosuppression, the Seven Up score serves as a vital tool for improving safety and quality of life for liver transplant recipients worldwide.